The Washington Post
New research by Prof. Andrew Lo shows that the criteria currently used to evaluate whether drugs are safe and effective is too strict, reports Carolyn Johnson for The Washington Post. The study suggests that, “for many devastating diseases, the current standards are too risk-averse, erring on the side of keeping drugs off the market.”